1. Home
  2. AUPH vs VECO Comparison

AUPH vs VECO Comparison

Compare AUPH & VECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • VECO
  • Stock Information
  • Founded
  • AUPH 1993
  • VECO 1945
  • Country
  • AUPH Canada
  • VECO United States
  • Employees
  • AUPH N/A
  • VECO N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • VECO Industrial Machinery/Components
  • Sector
  • AUPH Health Care
  • VECO Technology
  • Exchange
  • AUPH Nasdaq
  • VECO Nasdaq
  • Market Cap
  • AUPH 1.1B
  • VECO 1.2B
  • IPO Year
  • AUPH 1999
  • VECO 1994
  • Fundamental
  • Price
  • AUPH $8.19
  • VECO $20.57
  • Analyst Decision
  • AUPH Strong Buy
  • VECO Buy
  • Analyst Count
  • AUPH 2
  • VECO 7
  • Target Price
  • AUPH $11.50
  • VECO $30.43
  • AVG Volume (30 Days)
  • AUPH 1.4M
  • VECO 622.8K
  • Earning Date
  • AUPH 07-31-2025
  • VECO 08-05-2025
  • Dividend Yield
  • AUPH N/A
  • VECO N/A
  • EPS Growth
  • AUPH N/A
  • VECO N/A
  • EPS
  • AUPH 0.27
  • VECO 1.07
  • Revenue
  • AUPH $247,295,000.00
  • VECO $710,109,000.00
  • Revenue This Year
  • AUPH $12.15
  • VECO N/A
  • Revenue Next Year
  • AUPH $18.31
  • VECO $10.08
  • P/E Ratio
  • AUPH $30.78
  • VECO $19.31
  • Revenue Growth
  • AUPH 29.20
  • VECO 3.30
  • 52 Week Low
  • AUPH $5.15
  • VECO $16.92
  • 52 Week High
  • AUPH $10.67
  • VECO $49.25
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 54.75
  • VECO 56.54
  • Support Level
  • AUPH $7.91
  • VECO $20.14
  • Resistance Level
  • AUPH $8.07
  • VECO $20.41
  • Average True Range (ATR)
  • AUPH 0.24
  • VECO 0.55
  • MACD
  • AUPH -0.00
  • VECO 0.06
  • Stochastic Oscillator
  • AUPH 51.85
  • VECO 82.49

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About VECO Veeco Instruments Inc.

Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for our customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.

Share on Social Networks: